Hepatitis C Virus Envelope Glycoprotein Signatures Are Associated With Treatment Failure and Modulation of Viral Entry and Neutralization | Zendy

Évelyne Schvoerer | Zendy; Rémy Moenne-Loccoz | Zendy; John M. Murray | Zendy; Aurélie Velay | Zendy; Marine Turek | Zendy; Isabel Fofana | Zendy; Samira FafiKremer | Zendy; Anne-Claire Erba | Zendy; François Habersetzer | Zendy; Michel Doffoël | Zendy; JeanPierre Gut | Zendy; Maureen J. Donlin | Zendy; John E. Tavis | Zendy; Mirjam B. Zeisel | Zendy; Françoise StollKeller | Zendy; Thomas F. Baumert | Zendy

Open Access

Hepatitis C Virus Envelope Glycoprotein Signatures Are Associated With Treatment Failure and Modulation of Viral Entry and Neutralization

Author(s) -

Évelyne Schvoerer,

Rémy Moenne-Loccoz,

John M. Murray,

Aurélie Velay,

Marine Turek,

Isabel Fofana,

Samira FafiKremer,

Anne-Claire Erba,

François Habersetzer,

Michel Doffoël,

JeanPierre Gut,

Maureen J. Donlin,

John E. Tavis,

Mirjam B. Zeisel,

Françoise StollKeller,

Thomas F. Baumert

Publication year - 2013

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jit032

Subject(s) - virology , glycoprotein , infectivity , hepatitis c virus , virus , neutralization , cd81 , antibody , viral envelope , biology , viral entry , hepacivirus , immunology , viral replication , microbiology and biotechnology

A major challenge for antiviral treatment of hepatitis C virus (HCV) infection is viral resistance, potentially resulting from the high variability of HCV envelope glycoproteins and subsequent selection of strains with enhanced infectivity and/or immune escape.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research